The review, from University of Rochester neuroscientist Maiken Nedergaard, proposes a link between sleep-dependent brain rhythms and dementia risk. It explains that sleep is a highly organized state that coordinates chemistry, blood vessel movement, and cerebrospinal fluid flow to clear waste.
Nedergaard’s lab discovered the glymphatic system in 2012: a brain-wide network that moves cerebrospinal fluid through tissue around blood vessels to remove metabolic waste. This system is especially active during sleep and is central to research on Alzheimer’s and other neurological disorders.
The article notes that neuromodulators change how the brain behaves in wake and sleep, and that during non-REM sleep these systems synchronize into slow oscillations about every minute. When rhythms are disrupted by aging, stress, psychiatric illness, cardiovascular disease, poor sleep, or some medications, the brain may clear toxic proteins less efficiently.
The review also highlights heart rate variability during sleep as a possible noninvasive biomarker tied to these rhythms; such measures tracked by wearables might help identify people at higher risk for cognitive decline.
Difficult words
- glymphatic system — brain network that moves fluid and waste
- cerebrospinal fluid — clear liquid around brain and spinal cord
- neuromodulator — chemical that changes how neurons actneuromodulators
- oscillation — regular back and forth brain rhythmslow oscillations
- synchronize — to make things happen at same time
- biomarker — a measurable sign of a medical condition
- wearable — an electronic device worn on the bodywearables
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Do you use a wearable that tracks sleep or heart rate? How could that data help show risk for memory problems?
- What habits could a person change to protect their sleep rhythms and brain health?
- Why might poor sleep or stress affect the brain's ability to clear toxic proteins?
Related articles
New oral Listeria vaccine shows promise against colorectal cancer
Researchers report a modified oral vaccine made from Listeria that primes immune cells in the gut and limits tumor growth in mice. The vaccine worked best when combined with immune checkpoint inhibitors and caused few side effects.
